inhaled insulin

Back in control of Afrezza, MannKind refocuses on endocrinologists to give launch a jolt
Back in control of Afrezza, MannKind refocuses on endocrinologists to give launch a jolt
Fierce Pharma Marketing
MannKind
Afrezza
diabetes
Sanofi
inhaled insulin
Flag link:
MannKind to Discuss U.S. Commercialization Update for Afrezza
MannKind to Discuss U.S. Commercialization Update for Afrezza
Yahoo
MannKind
Afrezza
inhaled insulin
diabetes
Flag link:
MannKind Regains Afrezza® Marketing Rights
MannKind Regains Afrezza® Marketing Rights
Yahoo
MannKind
Afrezza
Sanofi
inhaled insulin
diabetes
Flag link:
The Lesson Of MannKind Corporation
The Lesson Of MannKind Corporation
Seeking Alpha
MannKind
Sanofi
Afrezza
diabetes
inhaled insulin
Flag link:
MannKind Corp. Sinks Again On Bankruptcy Concerns
MannKind Corp. Sinks Again On Bankruptcy Concerns
Motley Fool
MannKind
bankruptcy
Afrezza
Sanofi
inhaled insulin
diabetes
Flag link:
MannKind Corporation Announces Termination of License and Collaboration Agreement With Sanofi
MannKind Corporation Announces Termination of License and Collaboration Agreement With Sanofi
Yahoo
MannKind
Afrezza
Sanofi
diabetes
inhaled insulin
Flag link:
The Clock Is Ticking for MannKind
The Clock Is Ticking for MannKind
Motley Fool
MannKind
Sanofi
Afrezza
inhaled insulin
diabetes
Flag link:
How Sanofi Is Building For MannKind's Afrezza
How Sanofi Is Building For MannKind's Afrezza
Seeking Alpha
Sanofi
MannKind
diabetes
Afrezza
inhaled insulin
Flag link:
MannKind: Failure to Launch
MannKind: Failure to Launch
Barron's
MannKind
Afrezza
diabetes
Sanofi
inhaled insulin
Flag link:
MannKind And Afrezza: Can The Drug Cure The Company?
MannKind And Afrezza: Can The Drug Cure The Company?
Forbes
MannKind
Afrezza
diabetes
inhaled insulin
Flag link:
3 Reasons Why Afrezza's Launch Has Been So Disappointing
3 Reasons Why Afrezza's Launch Has Been So Disappointing
Motley Fool
Afrezza
MannKind
inhaled insulin
diabetes
Sanofi
insulin
Flag link:
MannKind Cheered Despite Lower Afrezza Shipments
MannKind Cheered Despite Lower Afrezza Shipments
24/7 Wall St
Afrezza
diabetes
insulin
MannKind
Sanofi
inhaled insulin
Flag link:
Sanofi and MannKind launch Afrezza DTC ad campaign in stealth mode
Sanofi and MannKind launch Afrezza DTC ad campaign in stealth mode
Fierce Pharma Marketing
Sanofi
MannKind
DTC
Afrezza
diabetes
inhaled insulin
insulin
Flag link:
Afrezza sales still underperforming, but MannKind remains optimistic
Afrezza sales still underperforming, but MannKind remains optimistic
BioPharma Dive
Afrezza
diabetes
insulin
inhaled insulin
MannKind
Sanofi
Flag link:
MannKind Afrezza Sales Underwhelming Again, Sanofi Reports
MannKind Afrezza Sales Underwhelming Again, Sanofi Reports
TheStreet.com
MannKind
Afrezza
Sanofi
diabetes
insulin
inhaled insulin
Flag link:
Sanofi/MannKind might be facing a major flop with Afrezza inhaled insulin
Sanofi/MannKind might be facing a major flop with Afrezza inhaled insulin
BioPharma Dive
MannKind
Sanofi
inhaled insulin
insulin
diabetes
Flag link:
MannKind's Afrezza Lags Behind Biggest Failure in Inhaled Insulin
MannKind's Afrezza Lags Behind Biggest Failure in Inhaled Insulin
TheStreet.com
MannKind
Afrezza
diabetes
insulin
inhaled insulin
Exubera
Flag link:
MannKind's Afrezza: Another Look At The Early Adopters
MannKind's Afrezza: Another Look At The Early Adopters
Seeking Alpha
MannKind
Afrezza
diabetes
inhaled insulin
insulin
Sanofi
Flag link:
Launching MannKind's Afrezza: Sanofi's 4 Laws Of Success
Launching MannKind's Afrezza: Sanofi's 4 Laws Of Success
Seeking Alpha
drug launches
MannKind
Afrezza
Sanofi
diabetes
inhaled insulin
Flag link:
What To Expect When Afrezza Goes Direct To Consumer
What To Expect When Afrezza Goes Direct To Consumer
Seeking Alpha
Afrezza
DTC
diabetes
inhaled insulin
MannKind
Sanofi
Flag link:

Pages